Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant
2011
Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells
2017
Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party
2007
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
FGFR2 -Amplified Gastric Cancer Cell Lines Require FGFR2 and Erbb3 Signaling for Growth and Survival
2008
Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial
2013
Haemolysis, pure red cell aplasia and red cell antibody formation associated with major and bidirectional ABO incompatible haematopoietic stem cell transplantation.
2018
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Donepezil for dementia due to Alzheimer's disease
2018
Calcium-dependent Regulation of Protein Kinase D Revealed by a Genetically Encoded Kinase Activity Reporter
2006 StandoutNobel
Outcomes of Adults with Acute Lymphoblastic Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation
2013
Computationally designed sensors detect endogenous Ras activity and signaling effectors at subcellular resolution
2024 StandoutNobel
The molecular hallmarks of epigenetic control
2016 Standout
AGA technical review on nausea and vomiting
2001
Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells
2003
Functional Gastroduodenal Disorders
2006 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy
2004
Contribution of platelets to tumour metastasis
2011 Standout
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
Activation of c-K-ras mutations in human gastrointestinal tumors
2000
Innate immunity in diabetic kidney disease
2020
Pharmacological targeting of Sam68 functions in colorectal cancer stem cells
2021
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
2009 Standout
Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
2008
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Vascular disorders of the liver # †
2008 Standout
The heterotrimeric G protein Gβ1 interacts with the catalytic subunit of protein phosphatase 1 and modulates G protein–coupled receptor signaling in platelets
2017
Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation
2011
Delivery technologies for cancer immunotherapy
2019 Standout
Thrombin signalling and protease-activated receptors
2000 StandoutNature
Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens
2001
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
2017
Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS
2022 StandoutNobel
Defective platelet activation in Gαq-deficient mice
1997 Nature
Fibroblast growth factor signalling: from development to cancer
2010 Standout
The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
2015
The Functional Gastrointestinal Disorders and the Rome III Process
2006 Standout
The ATP-gated P2X1 Receptor Plays a Pivotal Role in Activation of Aspirin-treated Platelets by Thrombin and Epinephrine
2008 StandoutNobel
Pure Red Cell Aplasia After ABO Major‐Mismatched Allogeneic Peripheral Blood Stem Cell Transplantation Successfully Treated with Plasma Exchange and Low‐Dose Steroid: Two Case Reports
2004
Chronic hepatitis B
2007 Standout
Epigenetic protein families: a new frontier for drug discovery
2012
Bioorganometallic chemistry—from teaching paradigms to medicinal applications
2008 Standout
Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study
2016
Hematopoietic Stem-Cell Transplantation
2006 Standout
Regulation of Phosphoinositide-specific Phospholipase C Isozymes
1997
A review of the biomaterials technologies for infection-resistant surfaces
2013 Standout
Comparison between 5-day decitabine and 7-day azacitidine for lower-risk myelodysplastic syndromes with poor prognostic features: a retrospective multicentre cohort study
2020
Tumour-inhibiting platinum complexes—state of the art and future perspectives
2003
Idarucizumab for Dabigatran Reversal
2015 Standout
The Pathophysiology and Treatment of Sepsis
2003 Standout
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
Systematic Review of Controlled Clinical Trials on the Use of Ursodeoxycholic Acid for the Prevention of Hepatic Veno-occlusive Disease in Hematopoietic Stem Cell Transplantation
2007
Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies
2007
Synergistic action between inhibition of P2Y12/P2Y1 and P2Y12/thrombin in ADP‐ and thrombin‐induced human platelet activation
2004 StandoutNobel
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
2014 Standout
A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification
2007
Asian‐Pacific consensus statement on the management of chronic hepatitis B: a 2005 update
2005
Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status
2014
Surface antimicrobial activity and biocompatibility of incorporated polyethylenimine nanoparticles
2008
Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion
2004
How do I approach ABO‐incompatible hematopoietic progenitor cell transplantation? (CME)
2011
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis
2001
Effects of human soluble thrombomodulin on experimental glomerulonephritis
2002 StandoutNobel
Factor V Leiden: A Clinical Review
2001
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets
2011 StandoutNobel
Pharmacotherapeutic strategies in the treatment of severe Alzheimer’s disease
2016
Furin‐Mediated Sequential Delivery of Anticancer Cytokine and Small‐Molecule Drug Shuttled by Graphene
2014
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Acute Myeloid Leukemia
2015 Standout
A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients
2015
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
New Ways to Use DNA Methyltransferase Inhibitors for the Treatment of Myelodysplastic Syndrome
2011
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Entecavir vs Lamivudine for Prevention of Hepatitis B Virus Reactivation Among Patients With Untreated Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy
2014
Structure, Function, and Control of Phosphoinositide-Specific Phospholipase C
2000
Graft-versus-leukemia effects of transplantation and donor lymphocytes
2008
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Potentiation of Thromboxane A2-induced Platelet Secretion by Gi Signaling through the Phosphoinositide-3 Kinase Pathway
2001
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
2014
Duration of immunosuppressive treatment for chronic graft-versus-host disease
2004
Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns
2010
Wound Healing: A Cellular Perspective
2018 Standout
Recent Developments in the Chemistry of Cubic Polyhedral Oligosilsesquioxanes
2010 Standout
Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation
2001
Viscoelastic properties of POSS–styrene nanocomposite blended with polystyrene
2009
Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins
2009
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
The relative role of PLCβ and PI3Kγ in platelet activation
2005
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation
2007
Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management
2005
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Molecular Basis for Interactions of G Protein βγ Subunits with Effectors
1998 StandoutScienceNobel
Hidden Killers: Human Fungal Infections
2012 Standout
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Helicobacter pylori and Extragastric Diseases
2014
World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes
2007
Cholinesterase inhibitors for Alzheimer's disease
2006 Standout
Works of Je‐Hwan Lee being referenced
Randomized Trial of Myeloablative Conditioning Regimens: Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine
2012
A 12-week clevudine therapy showed durable antiviral activity and normalization of alanine transminase levels for 6 months after discontinuation of treatment in patients with chronic hepatitis B.
2018
Benefits of hypomethylating therapy in IPSS lower-risk myelodysplastic syndrome patients: A retrospective multicenter case series study
2017
Feasibility of hypomethylating agents followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome
2011
Automated double red‐cell phlebotomy for the treatment of erythrocytosis
2012
Phase II Trial of a Novel Platinum Analog, SKI 2053R, in Patients With Previously Untreated Extensive-Stage Small-Cell Lung Cancer
1999
Donor-Derived Natural Killer Cells Infused after Human Leukocyte Antigen–Haploidentical Hematopoietic Cell Transplantation: A Dose-Escalation Study
2014
Comparison of 7-day azacitidine and 5-day decitabine for treating myelodysplastic syndrome
2013
Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study
1998
Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course
2003
Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation
2004
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia
2014
Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study
2005
Prognostic significance of Fas (CD95) and TRAIL receptors (DR4/DR5) expression in acute myelogenous leukemia
2003
Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome
2003
Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen–Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia
2016
A biocompatibility study of a reinforced acrylic‐based hybrid denture composite resin with polyhedraloligosilsesquioxane
2007
High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies
2010
Clinicopathologic significance of the K-ras gene codon 12 point mutation in stomach cancer. An analysis of 140 cases
1995
Graft‐versus‐host disease (GVHD)‐specific survival and duration of systemic immunosuppressive treatment in patients who developed chronic GVHD following allogeneic haematopoietic cell transplantation
2003
Changes of isoagglutinin titres after ABO‐incompatible allogeneic stem cell transplantation
2003
Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System
2019
Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation
2000
Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplantation: a prospective study
2000
Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice
2013
A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL
2011
Successful Treatment with Ganciclovir for Cytomegalovirus Duodenitis following Allogenic Bone Marrow Transplantation
1999
Plasminogen activator inhibitor‐1 is an independent diagnostic marker as well as severity predictor of hepatic veno‐occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulphan and cyclophosphamide
2002
Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
2005
Allogeneic stem cell transplantation in patients with de novo diffuse large B-cell lymphoma who experienced relapse or progression after autologous stem cell transplantation: a Korea–Japan collaborative study
2014
The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea
2013
Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse
2004
Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis
1998
Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome
2011
Donepezil 23 mg in Asian patients with moderate-to-severe Alzheimer's disease
2016
A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome
2015
Phase 1 study of CWP232291 in relapsed/refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
2015
A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia
2011
Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.
2005
Hepatic and small bowel mucormycosis after chemotherapy in a patient with acute lymphocytic leukemia
2000
Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome
2020
Immunohistochemical analysis of CD 123, CD 56 and CD 4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm
2012
Decreased expression of phospholipase C-beta 2 isozyme in human platelets with impaired function
1996